Correlation Between GlaxoSmithKline PLC and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and NLS Pharmaceutics AG, you can compare the effects of market volatilities on GlaxoSmithKline PLC and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and NLS Pharmaceutics.
Diversification Opportunities for GlaxoSmithKline PLC and NLS Pharmaceutics
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and NLS is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and NLS Pharmaceutics
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.14 times more return on investment than NLS Pharmaceutics. However, GlaxoSmithKline PLC ADR is 6.92 times less risky than NLS Pharmaceutics. It trades about -0.03 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.04 per unit of risk. If you would invest 4,042 in GlaxoSmithKline PLC ADR on November 3, 2024 and sell it today you would lose (515.00) from holding GlaxoSmithKline PLC ADR or give up 12.74% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| NLS Pharmaceutics |
GlaxoSmithKline PLC and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and NLS Pharmaceutics
The main advantage of trading using opposite GlaxoSmithKline PLC and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |